1 / 64

Clinical Pharmacology of Inhaled Anesthetics

Clinical Pharmacology of Inhaled Anesthetics. Dr. Greg Bryson Dept of Anesthesiology The Ottawa Hospital 2012.09.2 7. Objectives I. Chemical structure Structure - function relationships Physiochemical properties Definition of MAC Factors which affect MAC Mechanism of action

lola
Télécharger la présentation

Clinical Pharmacology of Inhaled Anesthetics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Clinical Pharmacology of Inhaled Anesthetics Dr. Greg Bryson Dept of Anesthesiology The Ottawa Hospital 2012.09.27

  2. Objectives I • Chemical structure • Structure - function relationships • Physiochemical properties • Definition of MAC • Factors which affect MAC • Mechanism of action • Uptake and Distribution

  3. Objectives II • Fa/Fi curves, and factors which affect them • Physiological effects of inhalation anesthetics: • Cardiovascular system • Respiratory system • Central nervous system • Neuromuscular junction • Others • Metabolism/toxicity of inhalation anesthetics

  4. The reality • You use these drugs every day • If you don’t know them – no one else does • None of this stuff is “new” • All of it is in the textbooks • Some of it is useful – some is “on the exam” • I can’t cover all of it in 3 hours

  5. Greg’s goals for this lecture • Inflict my view of what you should know • Put this in a clinical (read: useful) context • Explain that which needs explaining • Leave the memory work to you • Take my daughter to cross country practice

  6. Reference material • Miller 7th Edition • Chapter 20. Inhaled Anesthetics. Mechanisms of Action. • Chapter 21. Inhaled Anesthetics. Uptake and Distribution. • Chapter 22. Pulmonary Pharmacology. • Chapter 23. Cardiovascular Pharmacology. • Chapter 24. Inhaled Anesthetics. Metabolism and Toxicity.

  7. Nitrous Oxide Diethyl Ether Halothane Chemical structure I Xe Xenon

  8. Fun with chemistry • Alkanes precipitate arrythmias • Halogenationreduces flammability • Fluorination reduces solubility • Trifluorcarbon groups add stability

  9. F Cl H F Enflurane Isoflurane Sevoflurane Desflurane Chemical structure II

  10. Physical characteristics • Please cram the contents of table 15.1 from Barash 5th Ed the night before the exam. Take home points include: • desflurane boils at 24 OC • halothane is preserved with thymol • vapor pressures are needed for some exam questions • knowledge of blood:gas partition coefficients may actually be useful (uptake and distribution)

  11. Vapor pressure and vaporizer Fig 25-17. Miller 7th Ed

  12. Partition coefficients • Represent the relative affinity of a gas for 2 different substances (solubility) • Measured at equilibrium so partial pressures are equal, but... • The amounts of gas dissolved in each substance (concentration) aren’t equal. • The larger the number, the more soluble it is in the first substance

  13. Key Physical Properties Tables21.1 and 24.1. Miller 7th Ed * Old textbooks on my shelf

  14. Mechanism of Action Meyer-Overton Protein-interference Fig 20-2 Miller 7th Ed

  15. Mechanism of action II • Protein Receptor Hypothesis • ligand-gated ion channels (GABA, glycine, NMDA-glutamate) • voltage-gated ion channels (Na, K, Ca) • G-proteins (guanine nucleotide) • Protein kinase C • Site of action • Brain v spinal cord (amnesia v immobility) • Axonal v synaptic • Pre v post synaptic

  16. Minimum alveolar concentration • Alveolar concentration required to prevent movement in 50% of subjects • standard stimulus • represents brain concentration • consistent within and between species • Additive • Variants • BAR (1.7 – 2.0 MAC) • Awake (0.3 -0.5 MAC)

  17. Increasing age (6% per decade) Hypothermia Hyponatremia Hypotension (MAP<50mmHg) Pregnancy Hypoxemia (<38 mmHg) O2 content (<4.3 ml O2/dl) Metabolic acidosis Narcotics Ketamine Benzodiazepines 2 agonists LiCO3 Local anesthetics ETOH (acute) And many more... Factors decreasing MAC Table 15.5. Barash 5th Edition

  18. Factors increasing MAC • Hyperthermia • Chronic ETOH abuse • Hypernatremia • Increased CNS transmitters • MAOI • Amphetamine • Cocaine • Ephedrine • L-DOPA Table 15.4. Barash 5th Edition.

  19. Factors with no influence on MAC • Duration of anesthesia • Sex • Alkalosis • PCO2 • Hypertension • Anemia • Potassium • Magnseium • And others

  20. Uptake and distribution • Anesthesia depends upon brain partial pressure • Alveolar partial pressure (PA) = Pbrain • The faster PA approaches the desired level the faster the patient is anesthetized • PA is a balance between delivery of drug to the alveolus and uptake of that drug into the blood • Time for an analogy

  21. a b To induce anesthesia the bucket (PA) must be full. Unfortunately the bucket has a leak (uptake). To fill the bucket you must either (a) pour it in faster (increase delivery) or (b) slow down the leak (decrease uptake).

  22. Factors influencing uptake • Solubility (blood:gas pc) • Cardiac output • Alveolar-venous pressure gradient • For those of you who like formulae: Uptake =  • Q • (PA-Pv)/BP

  23. The blood:gas pc is useful, really. • Anesthesia is related to the partial pressure of the gas in the brain. • If a drug is dissolved in blood, it isn’t available as a gas • More molecules of a soluble gas are required to saturate liquid phase before increasing partial pressure • Speed of onset/offset closely related to solubility • The lower the blood:gas pc - the faster the onset

  24. FA/FI Curves

  25. Factors influencing delivery • Alveolar ventilation • Breathing system • volume • fresh gas flow • Inspired partial pressure (PI) • concentration effect • second gas effect

  26. Minute ventilation and uptake Figure 21-5. Miller 7th Ed

  27. Cardiac Output and Uptake Fig 21-7. Miller 7th Ed

  28. Concentration and 2nd gas effects 54% Fig 21.3 Miller 7th Ed

  29. Concentration and 2nd Gas Effects Fig 21.4. Miller 7th Ed

  30. V/Q distribution and uptake • Ventilation < perfusion (shunt) • blood leaving shunt dilutes PA from normal lung • induction with low solubility agent will be delayed • little difference with soluble agents (slow anyway) • Ventilation > perfusion (dead space) • uptake is decreased which enhances rise in FA • may speed induction for soluble agents • less difference with low solubility agents (fast anyway)

  31. Endobronchial intubation Figs 21 – 11 and 12. Miller 7th Ed.

  32. Break

  33. Objectives II • Physiological effects of inhalation anesthetics: • Cardiovascular system • Respiratory system • Central nervous system • Neuromuscular junction • Others • Metabolism/toxicity of inhalation anesthetics

  34. Effects on organ systems • Cardiovascular (Ch 23) • Pulmonary (Ch 22) • CNS (Ch 13) • Neuromuscular • Hepatic (Ch 66) • Renal (Ch 45) • Uterine (ch 69) • Miscellaneous

  35. Inhaled anesthetics - CV system • Effect is hard to quantify • In vitro and in vivo effects often quite different • Sympathetic stimulation • Baroreceptor reflexes • Animal model vs human subject • Information provided in this lecture is a broad overview. • Chapter 23, Miller 7thEd for details

  36. Myocardial contractility • All volatile anesthetics are direct myocardial depressants in vitro, including N2O. • Effect on circulation in vivo modified by effects on pulmonary circulation and sympathetic stimulation. • Ca++hemostasis in sarcoplasmic reticulum • As best as we can tell, at 1 MAC anesthetics depress contractility in the following order • H = E > I = D = S.

  37. Heart rate • Effects variable and agent-specific • halothane decreases HR • Sevoflurane and enflurane neutral • Desflurane associated with transient tachycardia • occurs with rapid increases in MAC • associated with increases in serum catecholamines • similar effect may be seen with isoflurane

  38. Blood pressure • All decrease BP, except N2O • Effect caused by a combination of • Vasodilation • Myocardial depression • Decreased CNS tone • Relative contribution of each is drug dependent

  39. Cardiac output • Despite myocardial depression cardiac output is well-maintained with isoflurane and desflurane • preservation of heart rate • greater reduction in SVR • preservation of baroreceptor reflexes

  40. Systemic vascular resistance • All are direct vasodilators, except N2O • relax vascular smooth muscle • cAMP - Ca++and/or nitric oxide involved • variable effects on individual vascular beds

  41. Dysrhytmias • Halothane potentiates catecholamine-related dysrhythmias • ED50 of epinehrine producing dysrhythmias at 1.25 MAC • halothane 2.1 g•kg-1 • isoflurane 6.9 g•kg-1 • enflurane 10.9g•kg-1 • Sevo + Des similar to isoflurane • Lidocaine doubles ED50 of epinephrine • Children somewhat more resistant Chapter 2. Stoelting P&P. 2nd Ed Chapter 5. Barash 5th ED

  42. Coronary blood flow • Isoflurane is a potent coronary vasodilator • In theory, dilation of normal coronary vessels can direct blood flow away from stenotic coronaries • Steal-prone anatomy • total occlusion of 1 major coronary vessel • collateral perfusion with 90% stenosis • In practice, doesn’t seem to be a problem

  43. Myocardial protection • Ischemic preconditioning • Volatiles appear able to replicate the effect • Activation of mitochondrial KATP channels • maintain Ca++hemostasis • prevent mitochondrial Ca++ overload • Inhibition of adenosine 1 (A1) receptors and guanine inhibitory (Gi) proteins abolish protection • Free radical scavenging (ROS)

  44. Respiratory system • Volatile anesthetics affect all aspects of RS • With exception of bronchodilation, none good. • For all the gory details (Chapter 22. Miller 7th Ed)

  45. Bronchial musculature • Reduce vagal tone • Direct relaxation • decreased intracellular Ca++ • decreased sensitivity to Ca++ • When bronchospastic, a dose dependent reduction in Raw occurs with most agents • Exception is Xenon • Increased viscosity causes increased Raw

  46. Mucociliary function + surfactant • Volatile anesthetics decrease ciliary beat • Decreased mucus clearance • Decreased production of phosphatidylcholine • PC used to make surfactant • occurs in as little as 4 hours • reversible in 2 hours

  47. Pulmonary blood flow • Intrinsic vasodilators • Hypoxic pulmonary vasoconstriction • Intrinsic changes in HPV confounded by • changes in cardiac output • pulmonary artery pressure • position • Shunt and PO2 appear unchanged in studies of inhaled anesthetics during one lung ventilation

  48. Control of ventilation • All decrease tidal volume • Most increase frequency • Net effect is: • decrease minute ventilation • increased PaCO2 (E>D=I>S=H) • Xenon appears to do the opposite • Decreased sensitivity and response to • Hypoxia • Hypercarbia • Inspiratory and expiratory loads

  49. Lung volumes • Decreased FRC • decreased intercostal muscle activity • phasic expiratory muscle activity • Cephalad displacement of dependent diaphragm • Dependent atelectasis

  50. Enclosed Air Spaces • N20 leaves blood 34x more than N2 absorbed • Sure, other agents are more soluble but we don’t give them at 70% end-tidal concentration • distension of closed air spaces • 70% N2O will double a pneumo in 10 minutes Fig 21-13 Miller 7th Ed.

More Related